Pfizer's Xalkori And The Progress In Lung Cancer Drugs | Biomarkers and Personalized Medicine | Scoop.it
Lung cancer is a tricky disease and there is a graveyard littered with lung cancer drugs that failed in clinical trial.Targeted approaches like Xalkori from Pfizer (PFE) and Tarceva from Roche (RHHBY.OB) work for small segmen...